Robert P. Schleimer

Active 1978–2025

177
Papers
29,053
Citations
109
h-index
174
i10-index

Citations

Citations per year for Robert P. Schleimer1980: 1 citations1982: 4 citations1983: 13 citations1984: 12 citations1985: 24 citations1986: 19 citations1987: 36 citations1988: 55 citations1989: 46 citations1990: 43 citations1991: 52 citations1992: 97 citations1993: 88 citations1994: 102 citations1995: 101 citations1996: 138 citations1997: 112 citations1998: 160 citations1999: 194 citations2000: 198 citations2001: 180 citations2002: 114 citations2003: 137 citations2004: 121 citations2005: 114 citations2006: 90 citations2007: 106 citations2008: 141 citations2009: 133 citations2010: 119 citations2011: 163 citations2012: 157 citations2013: 157 citations2014: 152 citations2015: 197 citations2016: 234 citations2017: 139 citations2018: 193 citations2019: 628 citations2020: 905 citations2021: 892 citations2022: 730 citations2023: 628 citations2024: 803 citations2025: 352 citations2026: 5 citations1981: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,848 citing papers, 30.1% of this breakdownUnited Kingdom: 710 citing papers, 7.5% of this breakdownChina: 644 citing papers, 6.8% of this breakdownGermany: 440 citing papers, 4.6% of this breakdownItaly: 388 citing papers, 4.1% of this breakdownCanada: 385 citing papers, 4.1% of this breakdownJapan: 384 citing papers, 4% of this breakdownFrance: 280 citing papers, 3% of this breakdownBelgium: 267 citing papers, 2.8% of this breakdownAustralia: 260 citing papers, 2.7% of this breakdownSpain: 244 citing papers, 2.6% of this breakdownNetherlands: 236 citing papers, 2.5% of this breakdown
0%30.1%Other 25.2%

Fields

  • Medicine69.2%
  • Immunology and Microbiology15.1%
  • Biochemistry, Genetics and Molecular Biology9.5%
  • Neuroscience2.3%
  • Nursing0.7%
  • Health Professions0.6%
  • Other2.6%

Topics

  • Asthma and respiratory diseases12.6%
  • Allergic Rhinitis and Sensitization8.1%
  • Sinusitis and nasal conditions6.4%
  • Food Allergy and Anaphylaxis Research3.4%
  • IL-33, ST2, and ILC Pathways3.4%
  • Mast cells and histamine2.9%
  • Other63.2%

Coauthors

All papers

Open in search
  1. Prevalence and Severity of Food Allergies Among US Adults

    Authors: , , , , , , , - JAMA Network Open 2019 cited by 1,006

  2. Chronic Rhinosinusitis with Nasal Polyps

    Authors: , , - The Journal of Allergy and Clinical Immunology In Practice 2016 cited by 545

  3. Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches

    Authors: , , , , , - Allergy 2021 cited by 279

  4. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis

    Authors: , , , , , , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2019 cited by 443

  5. Adult chronic rhinosinusitis

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2020 cited by 309

  6. Mechanisms and pathogenesis of chronic rhinosinusitis

    Authors: , , - Journal of Allergy and Clinical Immunology 2022 cited by 281

  7. Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis

    Authors: - Annual Review of Pathology Mechanisms of Disease 2016 cited by 538

  8. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease

    Authors: , , , , , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2017 cited by 275

  9. Chronic rhinosinusitis pathogenesis

    Authors: , , , - Journal of Allergy and Clinical Immunology 2015 cited by 390

  10. Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases

    Authors: , - Journal of Allergy and Clinical Immunology 2017 cited by 181

  11. Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps

    Authors: , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 120

  12. Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps

    Authors: , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2022 cited by 116

  13. Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample

    Authors: , , , , , , , , , , , - Allergy 2016 cited by 292

  14. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis

    Authors: , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2013 cited by 260

  15. Multi-omics colocalization with genome-wide association studies reveals a context-specific genetic mechanism at a childhood onset asthma risk locus

    Authors: , , , , , , , , , , , , , , , , , , , - Genome Medicine 2021 cited by 46

  16. Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin

    Authors: , - Journal of Allergy and Clinical Immunology 2020 cited by 158

  17. Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting

    Authors: , , , , , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2018 cited by 139

  18. The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease

    Authors: , - Tissue Barriers 2017 cited by 80

  19. TLR3- and Th2 Cytokine-Dependent Production of Thymic Stromal Lymphopoietin in Human Airway Epithelial Cells

    Authors: , , , - The Journal of Immunology 2007 cited by 487

  20. Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease

    Authors: , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2016 cited by 150

  21. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2015 cited by 145

  22. Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 88

  23. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2015 cited by 297

  24. Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois

    Authors: , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2016 cited by 184